Role of Resection of the Primary in Metastatic Well-Differentiated Neuroendocrine Tumors
Sign Up to like & getrecommendations! Published in 2021 at "Pancreas"
DOI: 10.1097/mpa.0000000000001936
Abstract: Supplemental digital content is available in the text. Objective Resection of the primary (RP) in metastatic neuroendocrine tumor (NET) is controversial. The aim was to evaluate survival outcomes for RP in metastatic NET patients. Methods… read more here.
Keywords: primary metastatic; metastatic well; year; well differentiated ... See more keywords
A practical proposal on treatment sequencing of metastatic well-differentiated neuroendocrine tumours
Sign Up to like & getrecommendations! Published in 2023 at "Therapeutic Advances in Medical Oncology"
DOI: 10.1177/17588359231171041
Abstract: According to the neuroendocrine tumour (NET) characteristics, 3 to 7 different treatment options are available, corresponding to 6 to 5,040 theoretical different sequences. Even though each patient is unique and despite a large heterogeneity in… read more here.
Keywords: proposal treatment; treatment sequencing; metastatic well; practical proposal ... See more keywords
The NETPET Score: Combining FDG and Somatostatin Receptor Imaging for Optimal Management of Patients with Metastatic Well-Differentiated Neuroendocrine Tumors
Sign Up to like & getrecommendations! Published in 2017 at "Theranostics"
DOI: 10.7150/thno.19588
Abstract: Neuroendocrine tumors (NET) are often metastatic at the time of diagnosis. Metastatic well-differentiated (G1/G2) NET may display a wide range of behaviors, ranging from indolent to aggressive, even within apparently homogeneous categories. Thus, selecting the… read more here.
Keywords: fdg; management; metastatic well; well differentiated ... See more keywords